En Es
Categories

Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including clinical chemistry and immunoassay analyzers and hematology solutions. The company’s offerings are ideal for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics.
Silver member
Products Covid-19Summary
Close

Covid-19 Abbott Diagnostics

Clinical Laboratory

Molecular Diagnostics Analyzer
ALINITY m

The ALINITY m is a fully integrated and automated molecular diagnostics analyzer that uses innovative technology to deliver the next level of flexibility and efficiency to the lab. With its Readiflex technology, 20 onboard assay capacity and broad assay menu, the allows consolidation of 60% of routine PCR testing on one instrument.
More details

COVID-19 Antigen Test
BinaxNOW COVID-19 Ag Card

The BinaxNOW COVID-19 Ag Card rapid antigen test, which has received emergency use authorization (EUA) from the US Food and Drug Administration (FDA), offers results in 15 minutes and is available as an aid to diagnose the virus that causes COVID-19. The BinaxNOW test can be displayed on Abbott’s new optional app - available at no charge - for iPhone and Android devices called NAVICA. This first-of-its-kind app will allow people who test negative to have a temporary encrypted digital health pass that displays their results.
More details

COVID-19 Test
ID NOW COVID-19

The ID NOW COVID-19 test returns positive results in 13 minutes or less to enable immediate clinical decisions during the first patient visit. The easy to use ID NOW platform is designed for near-patient, point-of-care use in a variety of healthcare settings.
More details

Molecular Diagnostics System
ID NOW

The ID NOW is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases and uses isothermal nucleic acid amplification technology for providing molecular results in minutes. The intuitively designed instrument features a large visual touchscreen for displaying the results, eliminating transcription errors and the need for printing, while its small footprint saves bench space for use in any healthcare setting.
More details

SARS-CoV-2 Assay
Abbott RealTime SARS-CoV-2 Assay

The Abbott RealTime SARS-COV-2 Assay is a real-time (rt) reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the qualitative detection of nucleic acids from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs from patients who are suspected of COVID-19 by their healthcare provider. Engineered with dual target assay for RdRp and N-genes, it provides a fully automated solution to help laboratories address the urgent need for patient testing during the Coronavirus (COVID-19) pandemic.
More details

Sample Preparation System
m24sp

The m24sp is an instrument for laboratories with mid-throughput requirements that offers automated flexibility. An automated bench-top system with a small footprint, the m24sp features reliable extraction using mSample Preparation chemistry and variable extraction with ready-to-use and re-usable reagents plus flexible batch size.
More details

COVID-19 Antigen Test
Panbio COVID-19 Ag Rapid Test Device

The Panbio COVID-19 Ag Rapid Test Device is intended for patients suspected of current COVID-19 infection and identifies potentially contagious patients in 15 minutes. Using patient-friendly nasal or nasopharyngeal sample collection types, the high performance rapid test enables immediate treatment or isolation measures to minimize transmission.
More details

COVID-19 Anitibody Test
Panbio COVID-19 IgG/IgM Rapid Test Device

The Panbio COVID-19 IgG/IgM Rapid Test Device is an in vitro diagnostic rapid test for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human serum, plasma, venous and fingerstick whole blood. The test provides preliminary test results within 10-20 minutes and is not intended to be used as a donor screening test for SARS-CoV-2.
More details

SARS-CoV-2 Antibody Test
Panbio SARS-CoV-2 IgG ELISA

The Panbio SARS-CoV-2 IgG ELISA is an antibody test that helps identify individuals with immune response to SARS-CoV-2 and enables greater access for broad population surveillance. The test is compatible with manual ELISA, and is adaptable to semi-automated and fully-automated equipment, enabling easy deployment within a lab's existing infrastructure.
More details

SARS-CoV-2 Antibody Test
AdviseDx SARS-CoV-2 IgM Assay

The AdviseDx SARS-CoV-2 IgM assay is a chemiluminescent microparticle immunoassay (CMIA) intended for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum, serum separator tube and plasma (dipotassium EDTA, tripotassium EDTA, lithium heparin, lithium heparin separator tube, sodium heparin). The assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection and should not be used to diagnose acute SARS-CoV-2 infection.
More details

SARS-CoV-2 Antibody Test
SARS-CoV-2 IgG Assay

The SARS-CoV-2 IgG assay is a chemiluminescent microparticle immunoassay (CMIA) intended for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum, serum separator tube and plasma (ACD, CPD, CPDA-1, dipotassium EDTA, tripotassium EDTA, lithium heparin, lithium heparin separator tube, sodium citrate, sodium heparin). The assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection and should not be used to diagnose acute SARS-CoV-2 infection.
More details

SARS-CoV-2 Assay
Alinity m SARS-CoV-2 Assay

The Alinity m SARS-CoV-2 Assay is a real-time (rt) reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal and oropharyngeal swabs collected by a healthcare provider, from patients who are suspected of COVID-19 infection. The assay runs on the Alinity m system having a simple workflow with primary sample tube loading to provide operational efficiencies to curb the increasing testing volume with the existing lab staff.
More details
Close

About Abbott Diagnostics

Abbott Diagnostics provides medical diagnostic instruments, tests, automation and informatics solutions, including clinical chemistry and immunoassay analyzers and hematology solutions. The company’s offerings are ideal for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics.
FaceBook Twitter Google+ Linked in
Bladder Cancer Kit

Bladder Cancer Kit

Model: UroVysion Kit
Request Information

Description:

The UroVysion Bladder Cancer Kit is designed to detect aneuploidy for chromosomes 3, 7, 17, and loss of the 9p21 locus via fluorescence in situ hybridization (FISH) in urine specimens from persons with hematuria suspected of having bladder cancer. It delivers definitive results in atypical cytology cases with equivocal or negative cystoscopy and is the only urine-based molecular test approved by the FDA to aid bladder cancer surveillance and assist with diagnosis.

Features Specifications

Features

• Proven clinical utility backed by more than 10 years of use with dozens of independent peer studies and publications
• Only urine-based molecular test approved by the FDA and CE marked to aid in the initial diagnosis of bladder cancer and subsequent monitoring for tumor recurrence
• Greater sensitivity in detecting bladder cancer than cytology across all stages and grades as it may identify chromosomal abnormalities before a tumor is visible
• UroVysion when used in conjunction with Cystoscopy improves sensitivity to 97%- more than either cystoscopy (74%) or cytology (58%) alone with 100% sensitivity in CIS tumors
• Delivers definitive results in atypical cytology cases with equivocal or negative cystoscopy
• Performs without interference in the presence of substances such as BCG, Mitomycin C and Thiotepia
• Positive UroVysion predicts recurrence during BCG therapy
• Delivers a 94.1% negative predicative value for the detection of bladder cancer recurrence versus cystoscopy/histology in BCG-treated patients Request Information

Specifications

UroVysion probe signals and DAPI counterstain should be viewed with the following Vysis filter sets:

DAPI single bandpass (DAPI counterstain)
Aqua single bandpass (chromosome 17)
Gold (Yellow) single bandpass (p16 gene)
Red/Green dual bandpass (chromosomes 3 and 7) Request Information

Send A Message To This Supplier

* Required Information
* Email
To
Abbott Diagnostics (Bladder Cancer Kit)
* Message

Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions